Skip to main content
Premium Trial:

Request an Annual Quote

Locus Pharmaceuticals To Use Invitrogen s SelectScreen Platform

NEW YORK, May 16 (GenomeWeb News) - Invitrogen will provide Locus Pharmaceuticals with kinase screening services through its SelectScreen platform, Invitrogen said today.

 

Invitrogen said that the platform will support Locus' discovery programs in the areas of cancer and inflammation.

 

Financial details of the transaction were not disclosed.

 

Invitrogen said that it has added 123 new human protein kinases to its SelectScreen screening panel over the last 14 months and that it will continue to expand the panel this year.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.